Why Value Analysis Is Becoming a Healthcare Governance Issue

For decades, value analysis has helped healthcare organizations answer a relatively straightforward question: does a product, technology, or service improve patient care while making good financial sense for the organization? The process was designed to bring together clinical and operational perspectives, balancing quality outcomes with responsible spending.

Today, that calculation has become far more complicated. Healthcare leaders are making decisions in an environment defined by financial pressures, workforce shortages, increasingly sophisticated technology, evolving regulatory expectations, and a growing reliance on third-party vendors. A decision that once focused primarily on cost and clinical efficacy now carries implications for cybersecurity, supply chain resilience, operational continuity, and long-term organizational risk.

As a result, value analysis is evolving into something larger than a procurement function. Increasingly, it serves as a governance framework that helps healthcare organizations make informed decisions across multiple competing priorities while keeping patient care at the center.

Value Means More Than Cost and Clinical Outcomes

The traditional goals of value analysis remain as important as ever. Healthcare organizations still need to understand whether a product improves patient outcomes, supports clinicians, and delivers an appropriate return on investment. But those questions are only part of the equation.

Consider the evaluation of a new technology platform. Clinical leaders may focus on its impact on patient care and staff workflows. Finance teams evaluate costs and reimbursement implications. IT departments assess integration requirements, while security teams examine cyber risks and data protection concerns. Supply chain leaders consider vendor stability and long-term support, and operations teams think about implementation and maintenance.

Each perspective is valid, but they are often evaluated through separate processes. The challenge for healthcare organizations is bringing those viewpoints together to understand the broader impact of a decision before it is made.

That is where value analysis can provide a strategic advantage. Rather than serving as a checkpoint in the procurement process, it can become a forum for evaluating the clinical, operational, financial, and organizational implications of major decisions in a coordinated way.

Vendor Relationships Have Become More Complex

The growing complexity of vendor relationships highlights why this evolution is necessary.

Hospitals rely on a vast network of third-party organizations to support patient care and daily operations. Medical device manufacturers are only one part of that ecosystem. Biomedical technicians, facilities contractors, environmental services teams, equipment maintenance providers, technology partners, food and nutrition services, and countless other vendors contribute to the functioning of a modern health system.

These relationships often extend beyond the products themselves. Vendors may access patient care environments, work with connected equipment, support critical infrastructure, or provide ongoing operational services that become essential to hospital performance.

Historically, different departments managed different aspects of these relationships. Procurement negotiated contracts. Clinical teams evaluated products. IT reviewed technology. Vendor credentialing managed access requirements. Security teams assessed cyber risks.

The problem is not that these processes exist. The problem is that they often operate independently despite evaluating different dimensions of the same vendor relationship. As healthcare organizations become increasingly dependent on third parties, those silos can make it difficult to identify risks and opportunities that cut across organizational boundaries.

Vendor Credentialing Reflects a Larger Shift

Vendor credentialing provides a useful example of how healthcare governance is changing.

For many years, credentialing programs focused primarily on clinical environments where the risks were most visible and immediate. The objective was straightforward: ensure that individuals entering sensitive patient care settings met established requirements for safety and compliance.

That model worked well for the challenges hospitals faced at the time. Today’s healthcare environment, however, depends on a much larger and more dynamic population of third-party personnel.

Service technicians, facilities contractors, maintenance providers, and technology specialists move throughout healthcare facilities every day, often responding to urgent operational needs. Hospitals generally know the companies they work with, but maintaining visibility into the individuals supporting those relationships can be far more complicated.

Leading health systems are beginning to address this challenge by viewing credentialing as part of a broader vendor governance strategy rather than an isolated compliance activity. Information about vendor access, performance, compliance, and organizational relationships becomes part of a larger decision-making framework that supports supply chain, operations, and value analysis efforts.

The goal is not to create more administrative work. It is to establish a clearer understanding of the third-party ecosystem that hospitals depend on every day.

Better Decisions Require Better Collaboration

As value analysis takes on a broader governance role, one principle should remain constant: the people closest to patient care and daily operations need a seat at the table.

Some of the most valuable information about products and vendor relationships comes from frontline clinicians and operational staff. Nurses, physicians, surgical teams, biomedical engineers, facilities personnel, and department managers understand how products perform under real-world conditions. They know where workflows succeed, where they create friction, and where service expectations fail to match reality.

Those insights become increasingly important as healthcare organizations evaluate more complex technologies and vendor relationships. A product may meet financial objectives and technical requirements while creating unintended challenges for clinical teams. At the same time, frontline staff often identify opportunities to improve patient care and operational efficiency that might not emerge through a traditional procurement process.

The strongest value analysis programs recognize that no single stakeholder has a complete picture. Clinical, operational, financial, technology, and supply chain leaders all contribute different expertise, and better decisions emerge when those perspectives are brought together through a common governance process.

The Future of Value Analysis

Healthcare organizations are unlikely to become less complex in the years ahead. Financial pressures will continue, technology will evolve, and hospitals will rely on increasingly sophisticated networks of third-party partners to support patient care and operations.

The organizations that adapt most successfully will not necessarily be those with the most processes or the most oversight. They will be the ones that connect existing functions in a way that supports better decision-making across the enterprise.

Value analysis was originally designed to help healthcare organizations make informed purchasing decisions. Today, it has the opportunity to become something even more valuable: a governance framework that brings together clinical, operational, financial, and administrative perspectives to address the interconnected challenges facing modern healthcare.

Ultimately, the objective remains the same as it has always been. Better decisions lead to stronger operations, better support for clinicians, and better outcomes for the patients healthcare organizations serve.